Hepatic AMPK and Akt phosphorylation levels in SD- or HFD-fed mice. by Mami Shiwa (712070)

DataSheet_3_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

“…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”

DataSheet_4_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

“…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”

DataSheet_2_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

“…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”

DataSheet_1_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

“…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”

Dietary change improves weight gain, liver steatosis, glucose tolerance, and insulin resistance. by Mami Shiwa (712070)

Margins of stability. by Steven A. Thompson (22477818)

Table_3_Transcriptome Analysis Reveals Catabolite Control Protein A Regulatory Mechanisms Underlying Glucose-Excess or -Limited Conditions in a Ruminal Bacterium, Streptococcus bov... by Yaqian Jin (9346998)

Schematic of the treatment procedure. by Mohamed A. Al-Griw (14768580)

“…Conversely, VitD treatment altered this scenario into motor performance preservation, reducing oxidative splenic injury with a decrease in the percent apoptotic index. This protection was significantly correlated with preserving leukocyte counts and reduced MDA levels in both genders. …”

S1 Raw images - by Mohamed A. Al-Griw (14768580)

“…Conversely, VitD treatment altered this scenario into motor performance preservation, reducing oxidative splenic injury with a decrease in the percent apoptotic index. This protection was significantly correlated with preserving leukocyte counts and reduced MDA levels in both genders. …”

Inhibition of FleA by 2EHex or fucose results in a loss of mucin binding and greatly reduced phagocytosis by macrophages. by Sheena C. Kerr (495450)

“…<p>(A) Structures of fucopyranoside compounds. (B) Amount of compound required to inhibit binding of labeled FleA to mucin by 50% (IC50 [μM]). …”

Development of obesity, liver steatosis, glucose intolerance, and insulin resistance in high fat diet-fed mice. by Mami Shiwa (712070)

Animal grouping and treatment. by Yanlin Zou (12415810)

“…Compared with the model group, the petroleum ether extract-treated group showed significant differences in the levels of TNF-α (161.67±4.93, 106.33±3.21, 77.67±4.04 pg/mL) and IL-10 (291.77±4.93, 185.09±9.54, 141.33±1.53 pg/mL) on the 7^th, 14^th, and 21^st days; a significant difference in the content of TGF-<i>β</i>1 (75.68±3.06 pg/mL) on the 21^st day; and a significant difference in the level of VEGF (266.67±4.73, 311.33±10.50 pg/mL) on the 7^th and 14^th days respectively.…”

Change in percent contracture rate of wound (). by Yanlin Zou (12415810)

“…Compared with the model group, the petroleum ether extract-treated group showed significant differences in the levels of TNF-α (161.67±4.93, 106.33±3.21, 77.67±4.04 pg/mL) and IL-10 (291.77±4.93, 185.09±9.54, 141.33±1.53 pg/mL) on the 7^th, 14^th, and 21^st days; a significant difference in the content of TGF-<i>β</i>1 (75.68±3.06 pg/mL) on the 21^st day; and a significant difference in the level of VEGF (266.67±4.73, 311.33±10.50 pg/mL) on the 7^th and 14^th days respectively.…”

General observation of the wound. by Yanlin Zou (12415810)

“…Compared with the model group, the petroleum ether extract-treated group showed significant differences in the levels of TNF-α (161.67±4.93, 106.33±3.21, 77.67±4.04 pg/mL) and IL-10 (291.77±4.93, 185.09±9.54, 141.33±1.53 pg/mL) on the 7^th, 14^th, and 21^st days; a significant difference in the content of TGF-<i>β</i>1 (75.68±3.06 pg/mL) on the 21^st day; and a significant difference in the level of VEGF (266.67±4.73, 311.33±10.50 pg/mL) on the 7^th and 14^th days respectively.…”

Heat map analysis and the relative expression of proteins in pancreas at the termination of the experiment. by Christopher Mayer (529944)

Reduction in metabolic rate for single and multi-joint assistance devices. by Nicholas A. Bianco (9922523)

Western blot analysis of phospho-AKT. by Joseph A. Bauer (18531388)

(A) Kaplan-Meier survival curves showing 28-day survival rates between the two groups;(B) ROC analysis of death risk factors in SFTS patients with HLH. by Bo Zhang (6559)

Summary of multi-joint hip-flexion knee-flexion ankle-plantarflexion assistance. by Nicholas A. Bianco (9922523)